169 related articles for article (PubMed ID: 32554827)
1. Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment.
Barbosa M; Paredes S; Machado MJ; Almeida R; Marques O
Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32554827
[TBL] [Abstract][Full Text] [Related]
2. Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
Raj R; Elshimy G; Jacob A; Arya PVA; Unnikrishnan DC; Correa R; Myint ZW
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2337-2347. PubMed ID: 34156518
[TBL] [Abstract][Full Text] [Related]
3. Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma.
Sasagawa Y; Tachibana O; Nakagawa A; Koya D; Iizuka H
J Clin Neurosci; 2015 Mar; 22(3):601-3. PubMed ID: 25455737
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone agonist-induced pituitary apoplexy in treatment of prostate cancer: case report and review of literature.
Hands KE; Alvarez A; Bruder JM
Endocr Pract; 2007 Oct; 13(6):642-6. PubMed ID: 17954421
[TBL] [Abstract][Full Text] [Related]
5. Pituitary Apoplexy Secondary to Gonadotropin-Releasing Hormone Agonist for Breast Cancer.
Mastandrea K; Voica M; Tetlay M; Hasan F
JCEM Case Rep; 2023 May; 1(3):luad069. PubMed ID: 37908581
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist-induced pituitary apoplexy.
Keane F; Egan AM; Navin P; Brett F; Dennedy MC
Endocrinol Diabetes Metab Case Rep; 2016; 2016():160021. PubMed ID: 27284452
[TBL] [Abstract][Full Text] [Related]
7. Pituitary apoplexy after leuprolide.
Davis A; Goel S; Picolos M; Wang M; Lavis V
Pituitary; 2006; 9(3):263-5. PubMed ID: 16832587
[TBL] [Abstract][Full Text] [Related]
8. Late onset of pituitary apoplexy following gonadotropin-releasing hormone agonist for prostate cancer treatment.
Elshimy G; Raj R; Jacob A; Correa R
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35256375
[TBL] [Abstract][Full Text] [Related]
9. Pituitary apoplexy: a rare complication of leuprolide therapy in prostate cancer treatment.
Tanios G; Mungo NA; Kapila A; Bajaj K
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710301
[TBL] [Abstract][Full Text] [Related]
10. GnRH agonist-associated pituitary apoplexy: a case series and review of the literature.
Guarda FJ; Yu X; Shiraliyeva N; Haines MS; Bradbury M; Saylor PJ; Nachtigall LB
Pituitary; 2021 Oct; 24(5):681-689. PubMed ID: 33835355
[TBL] [Abstract][Full Text] [Related]
11. Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature.
Triviño V; Fidalgo O; Juane A; Pombo J; Cordido F
World J Clin Cases; 2019 Oct; 7(20):3259-3265. PubMed ID: 31667176
[TBL] [Abstract][Full Text] [Related]
12. Pituitary Apoplexy After Leuprolide Therapy in a Breast Cancer Patient: A Case Report.
Lee J; Hwang SC; Park ST
Brain Tumor Res Treat; 2023 Apr; 11(2):153-157. PubMed ID: 37151158
[TBL] [Abstract][Full Text] [Related]
13. Pituitary apoplexy induced by Gonadotropin-releasing hormone agonists for treating prostate cancer-report of first Asian case.
Huang TY; Lin JP; Lieu AS; Chen YT; Chen HS; Jang MY; Shen JT; Wu WJ; Huang SP; Juan YS
World J Surg Oncol; 2013 Oct; 11():254. PubMed ID: 24088191
[TBL] [Abstract][Full Text] [Related]
14. Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists.
Sinnadurai M; Cherukuri RK; Moses RG; Nasser E
J Clin Neurosci; 2010 Sep; 17(9):1201-3. PubMed ID: 20605467
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone-induced partial empty sella clinically mimicking pituitary apoplexy in a woman with a suspected non-secreting macroadenoma.
Foppiani L; Piredda S; Guido R; Spaziante R; Giusti M
J Endocrinol Invest; 2000 Feb; 23(2):118-21. PubMed ID: 10800766
[TBL] [Abstract][Full Text] [Related]
16. A Case of Pituitary Apoplexy Following Leuprolide Injection for Prostate Cancer.
Kim KW; Chee S; Sunkara N; Baker MH
R I Med J (2013); 2024 Feb; 107(2):7-9. PubMed ID: 38285742
[TBL] [Abstract][Full Text] [Related]
17. [Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration].
Hernandez Morin N; Huet D; Hautecouverture M
Ann Endocrinol (Paris); 2003 Jun; 64(3):227-31. PubMed ID: 12910066
[TBL] [Abstract][Full Text] [Related]
18. Pituitary apoplexy. Clinical course, endocrine evaluations and treatment analysis.
da Motta LA; de Mello PA; de Lacerda CM; Neto AP; da Motta LD; Filho MF
J Neurosurg Sci; 1999 Mar; 43(1):25-36. PubMed ID: 10494663
[TBL] [Abstract][Full Text] [Related]
19. Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.
Guerra Y; Lacuesta E; Marquez F; Raksin PB; Utset M; Fogelfeld L
Pituitary; 2010; 13(1):54-9. PubMed ID: 19842040
[TBL] [Abstract][Full Text] [Related]
20. Pituitary apoplexy induced by corticotrophin-releasing hormone in a patient with Cushing's disease.
Rotman-Pikielny P; Patronas N; Papanicolaou DA
Clin Endocrinol (Oxf); 2003 May; 58(5):545-9. PubMed ID: 12699434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
